ARTICLE | Clinical News
PEG-Intron pegylated interferon-alpha-2b regulatory update
February 12, 2001 8:00 AM UTC
ENZN partner Schering-Plough Corp. (SGP, Kenilworth, N.J.) submitted a supplemental BLA to the FDA for PEG-Intron powder for injection in combination with Rebetol ribavirin capsules to treat chronic...